ACS Central Science (Oct 2023)
Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections
- Jelena Konstantinović,
- Andreas M. Kany,
- Alaa Alhayek,
- Ahmed S. Abdelsamie,
- Asfandyar Sikandar,
- Katrin Voos,
- Yiwen Yao,
- Anastasia Andreas,
- Roya Shafiei,
- Brigitta Loretz,
- Esther Schönauer,
- Robert Bals,
- Hans Brandstetter,
- Rolf W. Hartmann,
- Christian Ducho,
- Claus-Michael Lehr,
- Christoph Beisswenger,
- Rolf Müller,
- Katharina Rox,
- Jörg Haupenthal,
- Anna K.H. Hirsch
Affiliations
- Jelena Konstantinović
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Andreas M. Kany
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Alaa Alhayek
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Ahmed S. Abdelsamie
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Asfandyar Sikandar
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Katrin Voos
- Department of Pharmacy, Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany
- Yiwen Yao
- Department of Internal Medicine V − Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany
- Anastasia Andreas
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Roya Shafiei
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Brigitta Loretz
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Esther Schönauer
- Department of Biosciences and Medical Biology, Division of Structural Biology, University of Salzburg, Salzburg, Austria
- Robert Bals
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Hans Brandstetter
- Department of Biosciences and Medical Biology, Division of Structural Biology, University of Salzburg, Salzburg, Austria
- Rolf W. Hartmann
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Christian Ducho
- Department of Pharmacy, Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany
- Claus-Michael Lehr
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Christoph Beisswenger
- Department of Internal Medicine V − Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany
- Rolf Müller
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Katharina Rox
- Department of Chemical Biology (CBIO), Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
- Jörg Haupenthal
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- Anna K.H. Hirsch
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)−Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany
- DOI
- https://doi.org/10.1021/acscentsci.3c01102
- Journal volume & issue
-
Vol. 9,
no. 12
pp. 2205 – 2215
Abstract
No abstracts available.